Danaher Corporation $DHR Shares Acquired by Baader Bank Aktiengesellschaft

by · The Cerbat Gem

Baader Bank Aktiengesellschaft grew its position in Danaher Corporation (NYSE:DHR – Free Report) by 22.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,606 shares of the conglomerate’s stock after acquiring an additional 1,741 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $1,740,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. MGO One Seven LLC lifted its holdings in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares during the period. UniSuper Management Pty Ltd lifted its holdings in shares of Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares during the period. Asahi Life Asset Management CO. LTD. acquired a new stake in shares of Danaher during the first quarter worth $539,000. Horizon Financial Services LLC lifted its holdings in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after purchasing an additional 8,160 shares during the period. Finally, Focus Partners Wealth lifted its holdings in shares of Danaher by 10.7% during the first quarter. Focus Partners Wealth now owns 196,682 shares of the conglomerate’s stock worth $40,328,000 after purchasing an additional 19,086 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Wells Fargo & Company decreased their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. UBS Group cut their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $246.35.

Read Our Latest Analysis on DHR

Insider Transactions at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 11.10% of the company’s stock.

Danaher Stock Up 1.1%

DHR opened at $192.54 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market cap of $137.87 billion, a P/E ratio of 40.97, a PEG ratio of 2.66 and a beta of 0.75. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The business’s fifty day simple moving average is $200.61 and its 200 day simple moving average is $198.55.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also